Internal AstraZeneca safety report sheds light on neurological condition suffered by vaccine trial participant
The report details how the study volunteer, a previously healthy 37-year-old woman, “experienced confirmed transverse myelitis” after receiving her second dose of the vaccine, and was hospitalized on September 5. … Read More
![]()

